Met overexpression confers HGF‐dependent invasive phenotype to human thyroid carcinoma cells in vitro

The proto‐oncogene c‐MET encodes the tyrosine kinase receptor for hepatocyte growth factor (HGF), a pleiotropic cytokine controlling growth, survival, motility, invasive migration, and differentiation of epithelial cells. Like several other epithelial neoplasms, thyroid carcinomas have been found to overexpress c‐MET at both the mRNA and protein level. The biological relevance of Met overexpression to thyroid carcinoma natural history, however, remains to be elucidated. Therefore, we analyzed Met expression and response to HGF in two cell lines established from human thyroid carcinomas. In both lines we observed that the overexpressed and constitutively tyrosine phosphorylated HGF receptor maintained biochemical responsiveness to the ligand. Both cell lines were also found to respond to HGF by consistently increasing their motility and invading in vitro reconstituted basal membranes. Conversely, no effect of HGF could be observed in proliferation and survival assays. These data show that overexpression of Met specifically confers to transformed thyroid cells a motile‐invasive phenotype that is dependent on exogenous HGF stimulation. J. Cell. Physiol. 180:365–371, 1999. © 1999 Wiley‐Liss, Inc.

[1]  W. Birchmeier,et al.  Hepatocyte growth factor/scatter factor induces a variety of tissue- specific morphogenic programs in epithelial cells , 1995, The Journal of cell biology.

[2]  J. Cooper,et al.  Mutational analysis of capping protein function in Saccharomyces cerevisiae. , 1996, Molecular biology of the cell.

[3]  L. Schmidt,et al.  Activating mutations for the met tyrosine kinase receptor in human cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Comoglio,et al.  c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. , 1991, Oncogene.

[5]  A. Bardelli,et al.  A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family , 1994, Cell.

[6]  Z Kraiem,et al.  Divergent effects of cytokines on human leukocyte antigen‐DR antigen expression of neoplastic and non‐neoplastic human thyroid cells , 1992, Cancer.

[7]  L. Cantley,et al.  The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. , 1991, The Journal of biological chemistry.

[8]  T. Hunter,et al.  Receptor protein-tyrosine kinases and their signal transduction pathways. , 1994, Annual review of cell biology.

[9]  A. Mantovani,et al.  In vitro and in vivo activation of endothelial cells by colony-stimulating factors. , 1991, The Journal of clinical investigation.

[10]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[11]  M. Ivan,et al.  Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells , 1997, Oncogene.

[12]  G. Michalopoulos,et al.  Mini-review the Many Faces of Hepatocyte Growth Factor: from Hepatopoiesis to Hematopoiesis Structural Properties of Hgf the Hgf Receptor , 1995 .

[13]  J Vandekerckhove,et al.  Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells , 1990, The Journal of cell biology.

[14]  W. Birchmeier,et al.  Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion , 1989, The Journal of cell biology.

[15]  P. Comoglio,et al.  The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors , 1991, International journal of cancer.

[16]  M. Pierotti,et al.  Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. , 1992, Oncogene.

[17]  M. Takahashi,et al.  Evidence for mutual interdependence of epithelium and stromal lymphoid cells in a subset of papillary carcinomas. , 1995, British Journal of Cancer.

[18]  K. Köhrer,et al.  Regulation of the HGF-receptor c-met in the thyroid gland. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[19]  P. Comoglio,et al.  Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells , 1994, The Journal of cell biology.

[20]  J. Massagué,et al.  Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. , 1996, Cancer surveys.

[21]  M. Santoro,et al.  A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases , 1987, Nature.

[22]  W. Birchmeier,et al.  Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. , 1992, The EMBO journal.

[23]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[24]  C. Cooper,et al.  Tyrosine kinase receptor indistinguishable from the c-met protein , 1989, Nature.

[25]  C. Cooper,et al.  Biosynthesis of the protein encoded by the c-met proto-oncogene. , 1989, Oncogene.

[26]  P. Comoglio,et al.  Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. , 1997, Cytokine & growth factor reviews.

[27]  P. Comoglio,et al.  EXPRESSION OF Met PROTEIN IN THYROID TUMOURS , 1996, The Journal of pathology.

[28]  M. Santoro,et al.  High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. , 1989, Oncogene.

[29]  C. Cooper,et al.  Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.

[30]  R. Poulsom,et al.  Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. , 1995, Cancer research.

[31]  H. Kobayashi,et al.  Modulation of Urokinase-type Plasminogen Activator and Ovarian Cancer Cell Invasion by in Vitro Inhibition of Updated Version Citing Articles E-mail Alerts Inhibition of in Vitro Ovarian Cancer Cell Invasion by Modulation of Urokinase- Type Plasminogen Activator and Cathepsin B , 2022 .

[32]  E Medico,et al.  Expression of the Met/HGF receptor in normal and neoplastic human tissues. , 1991, Oncogene.

[33]  L. Naldini,et al.  RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. , 1994, The EMBO journal.

[34]  A. Bardelli,et al.  Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction (*) , 1995, The Journal of Biological Chemistry.

[35]  M. Santoro,et al.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas , 1990, Cell.

[36]  E Medico,et al.  The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. , 1996, Molecular biology of the cell.

[37]  M. Santoro,et al.  Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers , 1994, Cancer.

[38]  C. Heldin,et al.  Ligand-induced dimerization of growth factor receptors: variations on the theme. , 1996, Cytokine & growth factor reviews.